FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2069897730> ?p ?o ?g. }

• W2069897730 abstract "Background: Retrospective studies assessing the impact of tamoxifen (Tam) metabolism and its active metabolite, endoxifen, on the efficacy of the treatment produced conflicting results. The prospective CYPTAM-BRUT 2 trial is ongoing1. In the present study we assessed if the level of Tam metabolites could be improved by doubling tamoxifen dose in breast cancer patients (pts) with any CYP2D6 genotype, poor (PM), intermediate (IM) and also extensive metabolizer (EM). Patients and methods: This multicenter, prospective, open-label trial included pts treated with Tam for ≥ 4 months. CYP2D6 activity was determined centrally by genotyping and phenotyping (dextromethorphan test). Liquid chromatography-tandem-mass spectrometry was used to measure Tam, N-desmethyltamoxifen (N-DMT), 4-hydroxytamoxifen (4-HT) and endoxifen twice at baseline (Tam 20 mg qd), then at days 30, 90 and 120 after having increased the dose to 20 mg bid. Endoxifen increase and the differences between genotype/phenotype subgroups were analyzed by ANOVA. Results: 76 pts were analyzed. Steady-state concentrations for Tam and its metabolites were reached in 30 days after doubling the dose. A range of 1.6 to 1.8 fold increase was observed. Geometric mean plasma concentrations in ng/ml (CV%) were: at baseline and day 30 respectively 134 (48) and 246 (46) for tamoxifen (p The level of endoxifen increased 1.4 to 1.7 folds in all genotype subgroups with geometric mean plasma concentrations in ng/ml (CV%): 6.9 (36) to 9.7 (24) in PMs (p = 0.7); 14.2 (69) to 20.7 (76) in IMs (p The occurrence of hot flashes and night sweating were followed prospectively. Endoxifen levels did not predict an increase in HF/NS events9 overall occurrence (OR = 1.01, CI95% 0.78–1.31 for HF and 1.01, CI95% 0.79–1.29 for NS). Twelve pts received CYP2D6 inhibitors. Nine pts did not complete the planned 4 months with tamoxifen 20 mg bid. The main reasons were mood disorders, hot flashes, headache and nausea. Self-reported treatment compliance assessed by monthly anonymous questionnaire was ≥ 95%, except 80–95% in 4 pts. Conclusions: This is the first trial reporting the impact of the increase of tamoxifen dose in all CYP2D6 genotypes, including EMs. Dose escalation of tamoxifen increased significantly the plasma level of endoxifen by similar ratio in all genotype subgroups. Because of a huge inter-individual variability genotyping and phenotyping are not adequate surrogate markers of endoxifen level. Very low endoxifen levels are observed even in pts classified as EM. Future trials aiming to improve the plasma level of endoxifen should consider direct measurement of the metabolite in plasma and adjust tamoxifen dose according to the initial level of the metabolite independently of the genotype. Reference 1. A. Dieudonne, Journal of Clinical Oncology, 2011; vol 29, No 15, suppl (May 20, 2011): TPS 140 Citation Information: Cancer Res 2012;72(24 Suppl):Abstract nr P6-04-05." @default.
• W2069897730 created "2016-06-24" @default.
• W2069897730 creator A5008111826 @default.
• W2069897730 creator A5031165822 @default.
• W2069897730 creator A5037441803 @default.
• W2069897730 creator A5039037384 @default.
• W2069897730 creator A5039236556 @default.
• W2069897730 creator A5040966314 @default.
• W2069897730 creator A5048167745 @default.
• W2069897730 creator A5051253848 @default.
• W2069897730 creator A5053452556 @default.
• W2069897730 creator A5056912526 @default.
• W2069897730 creator A5062973691 @default.
• W2069897730 creator A5080479738 @default.
• W2069897730 creator A5084898907 @default.
• W2069897730 date "2012-12-15" @default.
• W2069897730 modified "2023-09-25" @default.
• W2069897730 title "Abstract P6-04-05: Tamoxifen dose escalation based on endoxifen level: a prospective trial with genotyping, phenotyping and pharmacokinetics over 4 months." @default.
• W2069897730 doi "https://doi.org/10.1158/0008-5472.sabcs12-p6-04-05" @default.
• W2069897730 hasPublicationYear "2012" @default.
• W2069897730 type Work @default.
• W2069897730 sameAs 2069897730 @default.
• W2069897730 citedByCount "0" @default.
• W2069897730 crossrefType "proceedings-article" @default.
• W2069897730 hasAuthorship W2069897730A5008111826 @default.
• W2069897730 hasAuthorship W2069897730A5031165822 @default.
• W2069897730 hasAuthorship W2069897730A5037441803 @default.
• W2069897730 hasAuthorship W2069897730A5039037384 @default.
• W2069897730 hasAuthorship W2069897730A5039236556 @default.
• W2069897730 hasAuthorship W2069897730A5040966314 @default.
• W2069897730 hasAuthorship W2069897730A5048167745 @default.
• W2069897730 hasAuthorship W2069897730A5051253848 @default.
• W2069897730 hasAuthorship W2069897730A5053452556 @default.
• W2069897730 hasAuthorship W2069897730A5056912526 @default.
• W2069897730 hasAuthorship W2069897730A5062973691 @default.
• W2069897730 hasAuthorship W2069897730A5080479738 @default.
• W2069897730 hasAuthorship W2069897730A5084898907 @default.
• W2069897730 hasConcept C104317684 @default.
• W2069897730 hasConcept C112705442 @default.
• W2069897730 hasConcept C121608353 @default.
• W2069897730 hasConcept C126322002 @default.
• W2069897730 hasConcept C126894567 @default.
• W2069897730 hasConcept C135763542 @default.
• W2069897730 hasConcept C149151106 @default.
• W2069897730 hasConcept C185592680 @default.
• W2069897730 hasConcept C2777176818 @default.
• W2069897730 hasConcept C2777477808 @default.
• W2069897730 hasConcept C2779591118 @default.
• W2069897730 hasConcept C2781245242 @default.
• W2069897730 hasConcept C31467283 @default.
• W2069897730 hasConcept C33664856 @default.
• W2069897730 hasConcept C526171541 @default.
• W2069897730 hasConcept C530470458 @default.
• W2069897730 hasConcept C55493867 @default.
• W2069897730 hasConcept C62231903 @default.
• W2069897730 hasConcept C71924100 @default.
• W2069897730 hasConcept C98274493 @default.
• W2069897730 hasConceptScore W2069897730C104317684 @default.
• W2069897730 hasConceptScore W2069897730C112705442 @default.
• W2069897730 hasConceptScore W2069897730C121608353 @default.
• W2069897730 hasConceptScore W2069897730C126322002 @default.
• W2069897730 hasConceptScore W2069897730C126894567 @default.
• W2069897730 hasConceptScore W2069897730C135763542 @default.
• W2069897730 hasConceptScore W2069897730C149151106 @default.
• W2069897730 hasConceptScore W2069897730C185592680 @default.
• W2069897730 hasConceptScore W2069897730C2777176818 @default.
• W2069897730 hasConceptScore W2069897730C2777477808 @default.
• W2069897730 hasConceptScore W2069897730C2779591118 @default.
• W2069897730 hasConceptScore W2069897730C2781245242 @default.
• W2069897730 hasConceptScore W2069897730C31467283 @default.
• W2069897730 hasConceptScore W2069897730C33664856 @default.
• W2069897730 hasConceptScore W2069897730C526171541 @default.
• W2069897730 hasConceptScore W2069897730C530470458 @default.
• W2069897730 hasConceptScore W2069897730C55493867 @default.
• W2069897730 hasConceptScore W2069897730C62231903 @default.
• W2069897730 hasConceptScore W2069897730C71924100 @default.
• W2069897730 hasConceptScore W2069897730C98274493 @default.
• W2069897730 hasLocation W20698977301 @default.
• W2069897730 hasOpenAccess W2069897730 @default.
• W2069897730 hasPrimaryLocation W20698977301 @default.
• W2069897730 hasRelatedWork W2044015759 @default.
• W2069897730 hasRelatedWork W2069469265 @default.
• W2069897730 hasRelatedWork W2087756545 @default.
• W2069897730 hasRelatedWork W2090447992 @default.
• W2069897730 hasRelatedWork W2102591663 @default.
• W2069897730 hasRelatedWork W2113225995 @default.
• W2069897730 hasRelatedWork W2131246641 @default.
• W2069897730 hasRelatedWork W2325633056 @default.
• W2069897730 hasRelatedWork W2328399427 @default.
• W2069897730 hasRelatedWork W2333962656 @default.
• W2069897730 hasRelatedWork W2363407898 @default.
• W2069897730 hasRelatedWork W2488747917 @default.
• W2069897730 hasRelatedWork W2610828542 @default.
• W2069897730 hasRelatedWork W2791796316 @default.
• W2069897730 hasRelatedWork W2792297183 @default.
• W2069897730 hasRelatedWork W2863793278 @default.
• W2069897730 hasRelatedWork W2913028268 @default.
• W2069897730 hasRelatedWork W2944067094 @default.
• W2069897730 hasRelatedWork W3036119574 @default.
• W2069897730 hasRelatedWork W3186991779 @default.

• next